Metabolism of diacylglycerol in humans

Asia Pacific Journal of Clinical Nutrition

Volumn 16, Issue SUPPL.1, 2007, Pages 398-403

  Takase, Hideto ^a  

^a KAO CORPORATION   (Japan)

Author keywords

Diacylglycerol; Fat oxidation; Obesity; Postprandial hyperlipidemia; Type II diabetes

Indexed keywords

DIACYLGLYCEROL;

ARTERIOSCLEROSIS; CONFERENCE PAPER; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; METABOLISM; OBESITY; PHYSIOLOGY; POSTPRANDIAL STATE;

ARTERIOSCLEROSIS; DIGLYCERIDES; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; OBESITY; POSTPRANDIAL PERIOD;

EID: 34047105837     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Ford ES, Giles WH, Diets WH. Precalence of the Metabolic Syndrome Among US Adults; Findings from the Third National Health and Nutrition Examination Survey, J. Am. Med. Assoc. 2002; 287: 356-359.
2. Krauss RM, and Witson M. Obesity: Impact on Cardiovascular Disease, Circulation 1998; 98: 1472-1476.
3. Bray GA, Popkin BM. Dietary fat intake does affect obesity! Am J Clin Nutr 1998; 68: 1157-1173.
4. Heshka S, Anderson JW, Atkinson RL, Greenway FL, Hill JO, Phinney SD, Kolotkin RL, Miller-Kovach K, Pi-Sunyer FX. Weight Loss with Self-Help Compared with Structured Commercial Program, J. Am. Med. Assoc. 2003; 289: 1792-1798.
5. Jeffery RW, Hellestedt WL, French AA, and Baxter JE. A Randomized Trial of Counseling for Fat Restriction Versus Calorie Restriction in the Treatment of Obesity, Int. J. Obes. Relat. Metab. Disord. 1995; 19: 132-137.
6. Abdel-Nabey AA, Shehata AAY, Ragab MH, Rossel JB. Glycerides of cottonseed oils from Egyptian and other varieties. Riv Ital Sostanze Grasse 1992; 69: 443-447.
7. D'alonzo RP, Kozarek WJ, Wade RL. Glyceride composition of processed fats and oils determined by glass capillary gas chromatography. J Am Oil Chem Soc 1982; 59: 292-295.
8. Ogawa H, Okushima S. and Kodama H., The Cooking Characteristics of Diacylglycerol rich Cooking Oil When Preparing Dishes. J. Integr. Study Diet. Habits. 2001; 12: 100-108.
9. Barceló Mairata I., and Barceló Mairata F., Analysis of the lipid composition of the Virgin Olive Oil rom Majorca FASC 1985; 36:269-73.
10. Crossley A, Freeman IP, Hudson JF and Pierce JH., Acyl migration in diglycerides. J Chem Soc, 1959; 760-764.
11. Kodali DR, Tercyak A, Fahey DA and Small DM., Acyl migration in 1, 2-dipalmitoyl-sn-glycerol. Chem Phys Lipids 1990; 52: 163-70.
12. Watanabe T, Shimizu M, Sugiura M, Sato M, Kohori J, Yamada N and Nakanishi K., Optimization of Reaction Conditions for the Production of DAG Using Immobilized 1,3-Regiospecific Lipase Lipozyme RM IM. J Am Oil Chem Soc 2003; 80: 1201-1207.
13. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J cardiol 1998;81:7B-12B.
14. Sakata K, Miho N, Shirotani M, Yoshida H, Takada Y, Takada A. Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospatic angina with nearly normal coronary artery. Atherosclerosis 1998;136:225-31.
15. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 1999;99:2858-60
16. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM, Schaefer EJ. Remnant-like particle (RLP) cholesterol is an independent cardiovascular risk factor in women: results from the Framingham Heart Study. Atherosclerosis 2001;154:229-36.
17. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, Havekes L. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991;11:653-62
18. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb1992;12:1336-45.
19. Karpe F, Bard JM, Steiner G, Carlson LA, Fruchart JC, Hamsten A. HDLs and alimentary lipemia: studies in men with previous myocardial infarction at young age. Arterioscler Thromb 1993;13:11-22.
20. Karpe F, Dteiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994;106:83-97.
21. Taguchi H, Watanabe H, Onizawa K, Nagao T, Gotoh N, Yasukawa T, Tsushima R, Shimasaki H, Itakura H. Double-blind controlled study on the effects of dietary diacylglycerol on postprandial serum and chylomicron triacylglycerol responses in healthy humans. J Am Coll Nutr 2000;19:789-796.
22. Tada N, Watanabe H, Matsuo N, Tokimitsu I, Okazaki M. Dynamics of postprandial remnant-like lipoprotein particles in serum after loading of diacylglycerols. Clin Chim Acta 2001;311:109-117.
23. Takei A, Toi T, Takahashi H, Takeda Y, Moriwaki J, Takase H, Katsuragi Y. Nutritional effects of mayonnaise type solidified dressing prepared from diacylglycerol on human lipid metabolism and body fat. Journal of Nutritional Food (a Journal of Japanese Health and Nutrition Food Association) 2001; 41:89-101.
24. Tomonobu K, Hase T, Tokimitsu I. Dietary diacylglycerol in a typical meal suppresses postprandial increases in serum lipid levels compared with dietary triacylglycerol. Nutrition, 2006;22:128-135.
25. Takase H, Shoji K, Hase T, Tokimitsu I. Effect of diacylglycerol on postprandial lipid metabolism in non-diabetic subjects with and without insulin resistance. Atherosclerosis 2005;180: 197-204.
26. Tada N, Shoji K, Takeshita M, Watanabe H, Yoshida H, Hase T, Matsuo N, Tokimitsu I. Effects of diacylglycerol ingestion on postprandial hyperlipidemia in diabetes Clin Chim Acta 2005;353:87-94.
27. Kondo H, Hase T, Murase T, Tokimitsu I. Digestion and assimilation features of dietary DAG in the rat small intestine. Lipids 2003;38:25-30.
28. Nagao T, Watanabe H, Goto N, Onizawa K, Taguchi H, Matsuo N, Yasukawa T, Tsushima R, Shimasaki H and Itakura H., Dietary Diacylglycerol Suppresses Accumulation of Body Fat Compared to Triacylglycerol in Men in a Double-blind Controlled Trial. J Nutr 2000; 130: 792-797.
29. Maki KC, Davidson MH, Tsushima R, Matsuo N, Tokimitsu I, Umporowicz DM, Dicklin MR, Foster GS, Ingram KA, Anderson BD, Frost SD and Bell M., Consumption of Diacylglycerol Oil as Part of a Reduced-energy Diet Enhances Loss of Body Weight and Fat in Comparison with Consumption of a Triacylglycerol Control oil, Am J Clin Nutri 2002; 76: 1230-1236.
30. Katsuragi Y, Toi T, Yasukawa T, Effects of dietary diacylglycerol on obesity and hyperlipidemia. Official Journal of the Japanese Society of Human Dry Dock 1999;14: 258-262.
31. Otsuki K, Mori K, Takase H, Two years, long-term effects of dietary diacylglycerols on the risks of the metabolic syndrome. Official Journal of the Japanese Society of Human Dry Dock 2004;19:29-32.
32. Takase H, Kawashima H, Wakaki Y, Yasukawa T, Katsuragi Y, Uasunaga K, Mori K, Yamaguchi T, Hase T, Tokimitsu I, Koyama W. Effect of Long-Term Ad-Libitum Ingestion of Diacylglycerol on Body Weight in a Free-Living Environment The North American Association for the Study of Obesity Annual Scientific Meeting Nov.14-18, 2004 in Las Vegas (SESSION 178-P).
33. Matsuyama T, Shoji K, Wanatabe H, Shimizu M, Saotome Y, Nagao T, Matsuo N, Hase T, Tokimitsu I, Nayaka N. Effects of diacylglycerol oil on adiposity in obese children: Initial communication. J Pediatr Endocrinol Metab. 2006;19:795-804.
34. Teramoto T, Watanabe H, Ito K, Omata Y, Furukawa T, Shimoda K, Hoshino M, Nagao T, Naito S. Significant effects of diacylglycerol on body fat and lipid metabolism in patients on hemodialysis. Clin Nutr 2004;23:1122-1126.
35. Yamamoto K, Asakawa H, Tokunaga K, Watanabe H, Matsuo N, Tokimitsu I, Yagi N. Long-Term Ingestion of Dietary Diacylglycerol Lowers Serum Triacylglycerol in Type II Diabetic Patients ith Hypertriglyceridemia. J Nutr. 2001;131:3204-3207.
36. Yamamoto K, Takeshita M, Tokimitsu I, Watanabe H, Mizuno T, Asakawa H, Tokunaga K, Tatsumi T, Okazaki M, Yagi N. Diacylglycerol oil ingestion in type-2 diabetic patients with hypertriglyceridemia. Nutrition 2006;22:23-29.
37. Yamamoto K, Tomonobu K, Asakawa H, Tokunaga K, Hase T, Tokimitsu I, Yagi N. Diet therapy with diacylglycerol oil delays the progression of renal failure in type 2 diabetic patients with nephropathy. Diabetes Care 2006;29:417-419.
38. Taguchi H, Nagao T, Watanabe H, Onizawa K, Matsuo N, Tokimitsu I, Itakura H. Energy value and digestibility of dietary oil containing mainly 1,3-diacylglycerol are similar to those of triacylglycerol. Lipids 2001;36, 379-382.
39. Kamphuis M.M., Mela D.J., Westerterp-Plantenga M.S. Diacylglycerols affect substrate oxidation and appetite in humans. Am J Clin Nutr 2003;77:1133-9.
40. Saito S, Tomonobu K, Hase T, Tokimitsu I. Efects of diacylglycerol on postprandial energy expenditure and respiratory quotient in healthy subjects. Nutr. 2006;22:30-35.